Literature DB >> 2401238

The production of transforming growth factor-beta by chick growth plate chondrocytes in short term monolayer culture.

D E Gelb1, R N Rosier, J E Puzas.   

Abstract

Transforming growth factor-beta (TGF beta) is capable of regulating the proliferation and phenotypic expression of growth plate chondrocytes in culture. Chondrocytes were isolated from the growth plates from the long bones of 3- to 5-week-old chicks. Conditioned medium was harvested from short term monolayer cultures for the assay of TGF beta production by these cells. A receptor competition assay using [125I]TGF beta was used to quantitate the amount of TGF beta in the conditioned medium. Acid-activated conditioned medium contained 5.0 +/- 0.4 ng/ml TGF beta, while conditioned medium that had not been exposed to acid had undetectable levels of the peptide by this assay. The initial cell plating density was inversely related to the amount of TGF beta produced on a per cell basis. Growth plate chondrocytes separated by countercurrent centrifugal elutriation into maturationally distinct subpopulations had different rates of TGF beta production; hypertropic chondrocytes produced significantly more TGF beta (4.5 ng/10(6) cells) than the smallest chondrocytes isolated (2.3 ng/10(6) cells). A variety of other growth mediators were tested for their ability to influence TGF beta production by chondrocytes, and it was found that only basic fibroblast growth factor could significantly influence TGF beta production, producing a 6-fold increase in TGF beta recovered in the conditioned medium. The production of TGF beta by growth plate chondrocytes implicates it as an important autocrine or paracrine regulator in the process of endochondral calcification.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2401238     DOI: 10.1210/endo-127-4-1941

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  8 in total

1.  Comparative effect of embryonic mouse fibroblasts (Balb/c-3T3) on the proliferation of hormone-dependent (T-47D) and hormone-independent (MDA-MB-231) human breast cancer cell lines.

Authors:  G Chetrite; L Delalonde; J R Pasqualini
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

2.  Parathyroid hormone and transforming growth factor-beta1 coregulate chondrocyte differentiation in vitro.

Authors:  E Nasatzky; E Azran; D D Dean; B D Boyan; Z Schwartz
Journal:  Endocrine       Date:  2000-12       Impact factor: 3.633

3.  Heterogeneous engineered cartilage growth results from gradients of media-supplemented active TGF-β and is ameliorated by the alternative supplementation of latent TGF-β.

Authors:  Michael B Albro; Robert J Nims; Krista M Durney; Alexander D Cigan; Jay J Shim; Gordana Vunjak-Novakovic; Clark T Hung; Gerard A Ateshian
Journal:  Biomaterials       Date:  2015-11-18       Impact factor: 12.479

4.  Accumulation of exogenous activated TGF-β in the superficial zone of articular cartilage.

Authors:  Michael B Albro; Robert J Nims; Alexander D Cigan; Kevin J Yeroushalmi; Tamara Alliston; Clark T Hung; Gerard A Ateshian
Journal:  Biophys J       Date:  2013-04-16       Impact factor: 4.033

5.  Shearing of synovial fluid activates latent TGF-β.

Authors:  M B Albro; A D Cigan; R J Nims; K J Yeroushalmi; S R Oungoulian; C T Hung; G A Ateshian
Journal:  Osteoarthritis Cartilage       Date:  2012-07-31       Impact factor: 6.576

6.  Porcine osteochondrosis: deficiencies in transforming growth factor-beta and insulin-like growth factor-I.

Authors:  B H Thorp; S Ekman; S B Jakowlew; C Goddard
Journal:  Calcif Tissue Int       Date:  1995-05       Impact factor: 4.333

7.  Chondromodulin I is a bone remodeling factor.

Authors:  Yuko Nakamichi; Chisa Shukunami; Takashi Yamada; Ken-ichi Aihara; Hirotaka Kawano; Takashi Sato; Yuriko Nishizaki; Yoko Yamamoto; Masayo Shindo; Kimihiro Yoshimura; Takashi Nakamura; Naoyuki Takahashi; Hiroshi Kawaguchi; Yuji Hiraki; Shigeaki Kato
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

8.  Intravenous administration of anti-vascular endothelial growth factor humanized monoclonal antibody bevacizumab improves articular cartilage repair.

Authors:  Toshihiro Nagai; Masato Sato; Toshiharu Kutsuna; Mami Kokubo; Goro Ebihara; Naoshi Ohta; Joji Mochida
Journal:  Arthritis Res Ther       Date:  2010-09-24       Impact factor: 5.156

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.